241 related articles for article (PubMed ID: 19845874)
1. SKI knockdown inhibits human melanoma tumor growth in vivo.
Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
[TBL] [Abstract][Full Text] [Related]
2. SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.
Lin Q; Chen D; Timchenko NA; Medrano EE
Cell Cycle; 2010 May; 9(9):1684-9. PubMed ID: 20404506
[TBL] [Abstract][Full Text] [Related]
3. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
4. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis.
Medrano EE
Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
[TBL] [Abstract][Full Text] [Related]
6. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
7. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
8. c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling.
Taguchi L; Miyakuni K; Morishita Y; Morikawa T; Fukayama M; Miyazono K; Ehata S
Cancer Sci; 2019 Jun; 110(6):2063-2074. PubMed ID: 30972853
[TBL] [Abstract][Full Text] [Related]
9. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
10. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.
Le Scolan E; Zhu Q; Wang L; Bandyopadhyay A; Javelaud D; Mauviel A; Sun L; Luo K
Cancer Res; 2008 May; 68(9):3277-85. PubMed ID: 18451154
[TBL] [Abstract][Full Text] [Related]
12. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
[TBL] [Abstract][Full Text] [Related]
14. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
15. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
16. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
17. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
18. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
19. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling.
Sun Y; Liu X; Ng-Eaton E; Lodish HF; Weinberg RA
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12442-7. PubMed ID: 10535941
[TBL] [Abstract][Full Text] [Related]
20. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway.
Li J; Li P; Zhang Y; Li GB; Zhou YG; Yang K; Dai SS
Cell Signal; 2013 Jan; 25(1):159-67. PubMed ID: 22986000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
